Hepatitis C virus infection in intravenous drug users

被引：17
|
作者：
Harder, J
Walter, E
Riecken, B
Ihling, C
Bauer, TM
机构：
[1] Univ Freiburg, Med Klin, Innere Med Abt 2, Dept Pathol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Univ Hosp, Dept Med Gastroenterol Hepatol & Infect Dis 2, Freiburg, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 08期
关键词：
drug users; hepatitis C; liver function tests; liver histology;
D O I：
10.1111/j.1469-0691.2004.00934.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Intravenous drug use (IVDU) remains a major means of hepatitis C virus (HCV) transmission. In this study, 101 drug users were studied prospectively after cessation of IVDU. Of these, 75.8% were anti-HCV positive, and 71.4% had elevated levels of alanine aminotransferase. These levels decreased significantly within 1 month of IVDU cessation (p 0.02). Liver biopsies showed minimal or mild fibrosis in 32 (71%) of 45 subjects, and severe fibrosis in two (4.4%) subjects. Anti-HCV-positive intravenous drug users in this study presented with mild liver disease and variable stages of disease progression. Biochemical disease activity might be affected by IVDU.
引用
收藏
页码：768 / 770
页数：3
相关论文
共 50 条
  • [31] Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users
    Wu, NP
    Li, D
    Zhu, B
    Zou, W
    CHINESE MEDICAL JOURNAL, 2003, 116 (09) : 1318 - 1320
  • [32] Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users
    吴南屏
    李丹
    朱彪
    邹微
    Chinese Medical Journal, 2003, (09)
  • [33] Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users
    吴南屏
    李丹
    朱彪
    邹微
    中华医学杂志(英文版), 2003, (09) : 40 - 42
  • [34] HEPATITIS C VIRUS (HCV) INFECTION AND RE-INFECTION IN ILLICIT DRUG USERS
    Barrieshee, Ahmed
    Tossonian, Harout
    Grebely, Jason
    Raffa, Jesse D.
    Gallagher, Lesley
    Storms, Michelle M.
    Duncan, Fiona
    DeVlaming, Stanley
    Conway, Brian
    HEPATOLOGY, 2009, 50 (04) : 666A - 666A
  • [35] Prävention der Hepatitis C bei DrogenkonsumentenPrevention of hepatitis C virus infection in drug users
    Bernd Schulte
    H. Stöver
    A. Leicht
    K. Schnackenberg
    J. Reimer
    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2008, 51 : 1210 - 1217
  • [36] SEXUAL TRANSMISSION OF HEPATITIS-C VIRUS AND HIV-1 INFECTION IN FEMALE INTRAVENOUS-DRUG-USERS
    SALVAGGIO, A
    CONTI, M
    ALBANO, A
    PIANETTI, A
    MUGGIASCA, ML
    RE, M
    SALVAGGIO, L
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1993, 9 (03) : 279 - 284
  • [37] Molecular epidemiological analysis of hepatitis C virus infection among the intravenous drug users in Yamaguchi prefecture, Japan.
    Satoh, Y
    Hino, K
    Ren, FY
    Korenaga, M
    Okuda, M
    Yamashita, S
    Okita, K
    HEPATOLOGY, 2002, 36 (04) : 556A - 556A
  • [38] MOLECULAR EPIDEMIOLOGY OF HEPATITIS-C VIRUS-INFECTION AMONGST INTRAVENOUS-DRUG-USERS IN RURAL COMMUNITIES
    MAJID, A
    HOLMES, R
    DESSELBERGER, U
    SIMMONDS, P
    MCKEE, TA
    JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (01) : 48 - 51
  • [39] Hepatitis C Virus Subtypes Circulating Among Intravenous Drug Users in Lisbon, Portugal
    Calado, Rita Almeida
    Rocha, Maria Raquel
    Parreira, Ricardo
    Piedade, Joao
    Venenno, Teresa
    Esteves, Aida
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (04) : 608 - 615
  • [40] Hepatitis C Infection Among Intravenous Drug Users Attending Therapy Programs in Cyprus
    Demetriou, Victoria L.
    van de Vijver, David A. M. C.
    Hezka, Johana
    Kostrikis, Leondios G.
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (02) : 263 - 270
12345